Elevating Patient Care and Expanding Healthcare Horizons
In October 2024, Bora Pharmaceuticals acquired Pyros Pharmaceuticals, enhancing Upsher-Smith’s treatment offerings with the introduction of the first ready-to-use oral solution for infantile spasms. This strategic combination allows Upsher-Smith to integrate Pyros’ treatments into our comprehensive portfolio, furthering our commitment to advancing patient care and broadening our impact in the healthcare industry.
Strengthening Our Future through Strategic Mergers
In April 2024, Bora Pharmaceuticals acquired Upsher-Smith, leading to our merger with TWi Pharmaceuticals in July 2024. This strategic move allowed us to incorporate TWi’s products into our extensive portfolio. By uniting our diverse product range with TWi’s specialized R&D capabilities, we are set to fuel our pipeline and elevate product development to new heights. This integration not only enhances our ability to deliver innovative solutions but also reinforces our commitment to improving patient outcomes and advancing healthcare.
Search Open Opportunities
We are committed to the dynamic and ongoing training and development of our most important asset – our employees.
We offer positions in quality, human resources, operations, technical services, engineering, marketing, sales, legal, regulatory, IT, and finance. With these opportunities come a full range of employee benefits in an environment that is challenging, stimulating, and rewarding.